We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




LIMS to Be Deployed to FDA Testing Laboratories

By LabMedica International staff writers
Posted on 01 Feb 2012
A software-based laboratory information management system (LIMS) will be used to manage complicated processes and the analysis of the massive amounts of data generated by the US Food and Drug Administration (FDA) laboratories.

Abbott (Abbott Park, IL, USA) announced that the FDA would begin implementing Abbott’s STARLIMS software-based LIMS as part of the agency’s initiative to enhance FDA testing laboratories. More...


As part of a master agreement with Dovèl Technologies (McLean, VA, USA), a company that provides high-end software applications to government organizations, the FDA’s Office of Regulatory Affairs (ORA; Silver Spring, MD, USA) will begin deploying LIMS solutions from STARLIMS, developed to enhance testing of food and drug chemistries, devices, forensics material, and microbiology samples. The ORA operates chiefly five types of laboratories in 14 separate locations. The LIMS solution will provide the needed capability to manage the analytic workflow operations in ORA labs for about 825 users supporting sample accountability, data analysis, document control, report generation, and other lab operation functions.

“We’re looking forward to working on this important initiative,” said Isaac Friedman, head of Abbott’s STARLIMS business. “STARLIMS has a successful track record in implementing web-based LIMS for life sciences organizations, public health laboratories, and a number of federal agencies.”

Based in Hollywood (FL, USA), Abbott’s STARLIMS business is a provider of laboratory information management systems, with more than 20 years of LIMS experience. STARLIMS products help improve the effectiveness of laboratory-sampling processes, support compliance with domestic and international regulations and industry standards, and provide comprehensive reporting, monitoring, and analysis capabilities. STARLIMS software is used for quality assurance and control, testing, and monitoring, and research and development in government, manufacturing, and life sciences organizations.

Abbott is a global healthcare company focused on the discovery, development, manufacture, and marketing of pharmaceuticals and medical products, including nutrition products, devices, and diagnostics.

Related Links:
STARLIMS
Dovèl Technologies
US Food and Drug Administration’s Office of Regulatory Affairs


Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Real-Time PCR System
Gentier 96T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.